Study To Evaluate Efficacy, Safety And Tolerability Of Lyrica In Patients With Painful Diabetic Peripheral Neuropathy
Status:
Completed
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
Pregabalin has proven effective in previous clinical trails in other countries in relieving
neuropathic pain associated with postherpetic neuralgia and painful diabetic neuropathy.
This study is being conducted according to China registration requirement to submit a
reapplication with new local diabetic peripheral neuropathy study as a commitment plus the
existing data to apply for Lyrica "pain associated with postherpetic neuralgia" indication
after Lyrica "pain associated with postherpetic neuralgia" is approved.
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer Pfizer's Upjohn has merged with Mylan to form Viatris Inc.